Investor Relations

Always well informed.

Welcome

Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.

Press releases

New cooperation of LT technologies GmbH & Co. KG with TRES MEDICO, Malaysia

19. January 2023

Our affiliate LT technologies has entered a cooperation in the field of repair service with the Malaysian company TRES MEDICO, a 100% subsidiary of HG Medic Sdn Bhd, Malaysia.

Successful certification of FFP 2 masks with medical approval of LT technologies

28. September 2022

LT technologies has successfully passed the certification of the FFP2 masks with medical approval.

Vitruvia Medical AG reports first-half 2021 results in line with expectations. Board of Directors confirms full-year and 2022 forecasts

13. September 2021

Vitruvia Medical AG is right on target after the first six months of the year.

Ad-hoc News

Vitruvia Medical AG half-year results as of June 30, 2025

05. August 2025

Vitruvia Medical AG achieves results as expected in the first half of 2025. The Board of Directors confirms the forecast for the year as a whole.

Vitruvia Medical AG: Year End results as of December 31, 2024

03. May 2025

Vitruvia Medical AG achieved a result after taxes of CHF -173’775.93 in the past year 2024 compared to CHF -243’896.10 in the previous year.

Vitruvia Medical AG half-year results as of June 30, 2024

03. September 2024

Vitruvia Medical AG achieves results as expected in the first half of 2024. The Board of Directors confirms the forecast for the year as a whole.

Year End results as of December 31, 2023

02. May 2024

Vitruvia Medical AG achieved a result after taxes of CHF -243,864.40 in the past year 2023 compared to CHF -1,095,349.38 in the previous year.

Key performance indicatorsVitruvia Medical AG share

Number of shares

The share capital is CHF 2'511'578.00 and is divided into 2'511'578 registered shares, each with a nominal value of CHF 1.00

WKN

A2PDWF

ISIN

CH0461931419

Valor

CH046193141

Availability of shares

All registered shares are freely transferable.

End of fiscal year

December 31

Stock exchange

Munich Stock Exchange

Market segment

General open market

Initial listing

May 11, 2021

Financial reports

30.06.2025 | Half-year financial statements per Juni 30th Incl. Management report

28.05.2025 | Annual financial statement 2024 Vitruvia Medical AG

29.09.2023 | Half-year financial statements per Juni 30th Incl. Management report

01.05.2024 | Consolidated financial statement 2023 Vitruvia Medical AG

01.05.2024 | Annual financial statements 2023 Vitruvia Medical AG

29.09.2023 | Half-year consolidated financial statements as of June 30, 2023 incl. management report

Management Transactions

02.07.2021 | Director’s Dealing Vitruvia Medical AG

02.07.2021 | Director’s Dealing Vitruvia Medical AG

27.05.2021 | Director’s Dealing Vitruvia Medical AG

25.05.2021 | Director’s Dealing Vitruvia Medical AG

21.05.2021 | Director’s Dealing Vitruvia Medical AG